Evidence map›Paper›PMID 28134302›Full record

ArticleScientific reports2017

Implication of dorsostriatal D3 receptors in motivational processes: a potential target for neuropsychiatric symptoms in Parkinson's disease.

Mathieu Favier, Carole Carcenac, Guillaume Drui, Yvan Vachez, Sabrina Boulet, Marc Savasta, Sebastien Carnicella

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mathieu FavierInserm, U1216, F- 38000 Grenoble, France.
Carole CarcenacInserm, U1216, F- 38000 Grenoble, France.
Guillaume DruiInserm, U1216, F- 38000 Grenoble, France.
Yvan VachezInserm, U1216, F- 38000 Grenoble, France.
Sabrina BouletInserm, U1216, F- 38000 Grenoble, France.
Marc SavastaInserm, U1216, F- 38000 Grenoble, France.
Sebastien CarnicellaInserm, U1216, F- 38000 Grenoble, France.
Université Grenoble Alpes · FRGrenoble Institute of Neurosciences · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Beyond classical motor symptoms, motivational and affective deficits are frequently observed in Parkinson's disease (PD), dramatically impairing the quality of life of patients. Using bilateral 6-hydroxydopamine (6-OHDA) lesions of the substantia nigra pars compacta (SNc) in rats, we have been able to reproduce these neuropsychiatric/non-motor impairments. The present study describes how bilateral 6-OHDA SNc lesions affect the function of the main striatal dopaminergic (DA) receptor subtypes. Autoradiography was used to measure the levels of striatal DA receptors, and operant sucrose self-administration and neuropharmacological approaches were combined to investigate the causal implication of specific DA receptors subtypes in the motivational deficits induced by a dorsostriatal DA denervation. We found that D3 receptors (D

Indexed as

AnimalsCorpus StriatumDisease Models, AnimalDopamineGene ExpressionImmunohistochemistryMaleOxidopamineParkinson DiseaseRatsReceptors, Dopamine D3Substantia NigraSucroseTyrosine 3-MonooxygenaseDopamineOxidopamineReceptors, Dopamine D3SucroseTyrosine 3-Monooxygenase

Identifiers

PMID28134302
PMCPMC5278505
OpenAlexW2581768507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.